Ces Urol 2023, 27(4):213-221 | DOI: 10.48095/cccu2023027

Microwave ablation and its role in treatment of small renal tumors

Eva Korčáková1, 5, Hynek Mírka1, 5, Kristýna Štajdlová1, Roman Bosman2, Adriena Bartoš Veselá3, Tomáš Pitra3, Kristýna Pivovarčíková4, Milan Hora3
1 Klinika zobrazovacích metod LF UK a FN Plzeň
2 Klinika anesteziologie a resuscitace LF UK a FN Plzeň
3 Urologická klinika LF UK a FN Plzeň
4 Šiklův ústav patologie, Plzeň
5 Biomedicínské centrum, Plzeň

Korčáková E., Mírka H., Štajdlová K., Bosman R., Bartoš Veselá A., Pitra T., Pivovarčíková K., Hora M. Microwave ablation and its role in treatment of small renal tumors. Current diagnostic methods are capable of detection small kidney tumors, and many of them are found incidentally during imaging for a different indication. This increase the number of low-stage tumors opens the door to less invasive treatment techniques in situations, when active surveillance is not indicated. Microwave ablation (MWA) is one of thermal ablation methods, which is coming to the fore recently. Its advantage is minimal invasiveness, comfort for the patient and the interventional radiologist, and good results. The aim of this article is to summarize current knowledge about MWA in the therapy of small renal tumors. The recommendations given in this article are based on the current guidelines of international urological societies and our own experience with this method. A summary of the indication criteria, recommendations which tumors are suitable and unsuitable for treatment with MWA and how to monitor patients after the procedure are presented.

Keywords: Microwave ablation, treatment, tumor, kidney.

Received: August 16, 2023; Revised: September 18, 2023; Accepted: September 25, 2023; Prepublished online: September 25, 2023; Published: December 19, 2023 


References

  1. Dušek L, Mužík J, Kubásek M, et al. Epidemiologie zhoubných nádorů v České republice [internet]. Masarykova univerzita [2005]. [cit. 2023-6-12]. Available from: www: http://www.svod.cz. Verze 7.0 [2007], ISSN 1802-8861.
  2. Ljungberg B, Albiges L, Abu­‑Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022; 82: 399-410. Go to original source... Go to PubMed...
  3. Campell SC, Clark PE, Chang SS, et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow Up - part I. J Urol. 2021; 206: 199. Go to original source... Go to PubMed...
  4. Lee H, Lee JK, Kim K, et al. Risk of metastasis for T1a renal cell carcinoma. World J Urol. 2016; 34(4): 553-559. Go to original source... Go to PubMed...
  5. European association of urology. [internet]. Available from: www: https://uroweb.org/guidelines/renal­‑cell­‑carcinoma/chapter/diagnostic­‑evaluation.
  6. Yu J, Wang H, Cheng ZG, et al. Multicenter 10 -Year Oncologic Outcome of Ultrasound­‑Guided Percutaneous Microwave Ablation of Clinical T1 Renal Cell Carcinoma: Will It Stand the Test of Time? Eur. Radiol. 2022; 32: 89-100. Go to original source... Go to PubMed...
  7. Dai Y, Covarrubias D, Uppot R, Arellano RS. Image­‑Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. J Vasc. Interv. 2017; 28(12): p1617-1758. Go to original source... Go to PubMed...
  8. Schmit GD, Kurup AN, Weisbrod AJ, et al. Ablate: a renal ablation planning algorithm. Am J Roentgenol. 2014; 202: 894-903. Go to original source... Go to PubMed...
  9. Campbell SC, Uzzo RG, Karam JA, et al. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow­‑up: AUA Guideline: Part II. J Urol. 2021: 206-209. Go to original source... Go to PubMed...
  10. Válek V, Válek V, Mechl M. Využitî termoablačnîch metod v léčbě tumorů ledvin. Urol. praxi. 2022; 23(2): 80-84. Go to original source...
  11. Heidenreich A, Ravery V. Preoperative imaging in renal cell cancer. World J Urol. 2004; 22(5): 307-315. Go to original source... Go to PubMed...
  12. Leveridge M, Bostrom P, Koulouris G, et al. Imaging renal cell carcinoma with ultrasonography, CT and MRI. Nat Rev Urol. 2010; 7: 311-325. Go to original source... Go to PubMed...
  13. Mírka H, Korčáková E, Kastner, et al. Diffusion­‑weighted Imaging Using 3.0T MRI as a Possible Biomarker of Renal Tumors. In: Anticancer Res. 2015; 35(4): 2351-2357
  14. Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature. J Urol. 2016; 195(5): 1340-1347. Go to original source... Go to PubMed...
  15. Bertolotti L, Bazzocchi MV, Iemma E, et al. Radiofrequency ablation, cryoablation, and microwave ablation for the treatment of small renal masses: Efficacy and complication. Diagnostics. 2023; 13: 388. Go to original source... Go to PubMed...
  16. Cornelis FH, Marcelin C, Bernhard JC. Microwave ablation of renal tumors: a narrative review of technical considerations and clinical resuts. Diagn. interv. imaging. 2017; 98: 287-297. Go to original source... Go to PubMed...
  17. Kim CH. Understanding the nuances of microwave ablation for more accurate post­‑treatment assessment. Future Oncol. 2018; 14(17): 1755-1764. Go to original source... Go to PubMed...
  18. Kurup AN. Percutaneous ablation for small renal masses­‑complications. Semin Intervent. Radiol. 2014; 31(1): 42-49. Go to original source... Go to PubMed...
  19. Lee JSZ, Hall J, Sutherland T. Complications of renal interventions: a pictorial review of CT findings. Insights Imaging. 2021; 12(1): 102. Go to original source... Go to PubMed...
  20. Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg. 2004; 240(2): 205-213. Go to original source... Go to PubMed...
  21. European association of urology. [internet]. Available from: www: https://uroweb.org/guidelines/renal­‑cell­‑carcinoma/chapter/disease­‑management.
  22. Castellana R, Natrella M, Fanelli G, et al. Efficacy and safety of MWA versus RFA and CA for renal tumors: a systematic review and meta­‑analysis of comparison studies. Eur J Radiol. 2023; 165: 110943 Go to original source... Go to PubMed...
  23. Martin J, Athreya S. Meta­‑analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome? Diagn Interv Radiol. 2013; 19(6): 501-7. Go to original source... Go to PubMed...
  24. Meng H, Yang H, Jia H, et al. Efficacy and safety of CT­‑guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney. Int J Hyperthermia. 2021; 38(1): 691-695. Go to original source... Go to PubMed...
  25. Aarts BM, Gomez FM, Lopez­‑Yurda M, et al. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Eur. Radiol. 2023; 33: 1040-1049. Go to original source... Go to PubMed...
  26. Yu J, Zhang Y, Liu H, et al. Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma. A propensity­‑matched cohort study of 1955 patient. Radiology. 2020; 294: 698-706. Go to original source... Go to PubMed...
  27. Uhlig J, Strauss A, Rucker G, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta­‑analysis. Eur. Radiol. 2019; 29:1293-1307. Go to original source... Go to PubMed...
  28. Pierorazio PM, Johnson MH, Patel HD, et al. Management of Renal Masses and Localized Renal Cancer. J Urol. 2016; 196(4): 989-999. Go to original source... Go to PubMed...
  29. Abboud SE, Patel T, Soriano S, et al. Long­‑Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center. Curr Probl Diagn Radiol. 2018; 47(2): 98-102. Go to original source... Go to PubMed...
  30. Thompson S, Schmitz JJ, Houston Thompson R, et al. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned. Am. J Roentgenol. 2018; 211: 1381-1389. Go to original source... Go to PubMed...
  31. Válek V, Rohan T, Andrašina T, et al. Srovnání celkového přežití u pacientů po resekci a perkutánní ablaci pro tumor ledviny. Ces. Radiol. 2022; 76(1): 32-37.





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit